Donata Micello
Overview
Explore the profile of Donata Micello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lozito A, Gemelli M, Micello D, Vinci V, Pelosi G, Ricotta R
Immunotherapy
. 2023 Jul;
15(13):1001-1007.
PMID: 37431623
PD-1/PDL-1 inhibitors have revolutionized cancer treatment, especially in lung cancer. Despite their efficacy, a new spectrum of side effects, called immune-related adverse events, may occur and their management could be...
2.
Carnevali I, Tedaldi G, Pensotti V, Sahnane N, Micello D, Rovera F, et al.
Front Oncol
. 2022 Jun;
12:891426.
PMID: 35686104
Background: Lobular breast carcinoma (LBC) is considered an exceptionally rare disease in men, including only 1% of all male breast malignancies. The majority of LBCs have negative immunohistochemical staining for...
3.
Micello D, Bossi A, Marando A, Dainese E, Sessa F, Capella C
Virchows Arch
. 2017 May;
471(1):13-21.
PMID: 28550498
Calretinin expression has been reported in neoplasms arising in various organs, including the breast. We investigated the relationship of calretinin expression with different histological and molecular subtypes of invasive breast...
4.
Finzi G, Micello D, Wizemann G, Sessa F, Capella C
Ultrastruct Pathol
. 2012 Apr;
36(2):124-9.
PMID: 22471435
PEComas (perivascular epithelioid cell tumors) represent a group of mesenchymal neoplasms showing characteristic morphologic, immunohistochemical, ultrastructural, and genetic features. These neoplasms are usually considered benign, being often well circumscribed by...
5.
Micello D, Marando A, Sahnane N, Riva C, Capella C, Sessa F
Virchows Arch
. 2010 Sep;
457(4):467-76.
PMID: 20809337
The estrogen receptor (ER)/progesterone receptor (PR)-negative breast carcinomas (BCs) encompass three molecular subtypes: one with human epidermal growth factor receptor 2 (HER) overexpression, one normal like, and the triple negative....
6.
Stathis A, La Rosa S, Proserpio I, Micello D, Chini C, Pinotti G
Tumori
. 2009 Apr;
95(1):119-22.
PMID: 19366071
Cytomegalovirus (CMV) is an opportunistic pathogen causing different diseases in immunocompromised patients and leading to death in a high percentage of cases. CMV infection is also relatively frequent among patients...
7.
La Rosa S, Bernasconi B, Micello D, Finzi G, Capella C
Endocr Pathol
. 2008 Dec;
20(1):24-34.
PMID: 19096940
Poorly differentiated neuroendocrine carcinomas (PDNECs) of the kidney are extremely rare high-grade cancers accounting for only 42 cases reported in the literature. In this paper, we describe the morphological, immunohistochemical,...